# Kinsale Capital Group, Inc.: financial statements, quarterly

KNSL · NYSE · CIK 1669162 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/knsl.md) · [Financials](/companies/knsl/financials.md) · [Filings](/companies/knsl/filings.md) · [Insiders](/companies/knsl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/knsl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [351 d](/filings/0001669162-26-000015.md) | [373](/filings/0001669162-25-000027.md) | [385](/filings/0001669162-25-000043.md) | [418](/filings/0001669162-25-000058.md) | [412 d](/filings/0001669162-26-000015.md) | [423](/filings/0001669162-26-000026.md) | [470](/filings/0001669162-26-000040.md) | [498](/filings/0001669162-26-000050.md) | [483 d](/filings/0001669162-26-000015.md) | [467](/filings/0001669162-26-000026.md) | [549](/filings/0001669162-26-000040.md) | [455](/filings/0001669162-26-000050.md) |
| Income tax | $m | [26.6 d](/filings/0001669162-26-000015.md) | [16.9](/filings/0001669162-25-000027.md) | [23.2](/filings/0001669162-25-000043.md) | [30.2](/filings/0001669162-25-000058.md) | [29.6 d](/filings/0001669162-26-000015.md) | [23.1](/filings/0001669162-26-000026.md) | [34.2](/filings/0001669162-26-000040.md) | [37.2](/filings/0001669162-26-000050.md) | [36.2 d](/filings/0001669162-26-000015.md) | [27.1](/filings/0001669162-26-000026.md) | [43.9](/filings/0001669162-26-000040.md) | [25.5](/filings/0001669162-26-000050.md) |
| Net income | $m | [103 d](/filings/0001669162-26-000015.md) | [98.9](/filings/0001669162-25-000058.md) | [92.6](/filings/0001669162-25-000058.md) | [114](/filings/0001669162-25-000058.md) | [109 d](/filings/0001669162-26-000015.md) | [89.2](/filings/0001669162-26-000050.md) | [134](/filings/0001669162-26-000050.md) | [142](/filings/0001669162-26-000050.md) | [139 d](/filings/0001669162-26-000015.md) | [113](/filings/0001669162-26-000050.md) | [176](/filings/0001669162-26-000050.md) | [98.1](/filings/0001669162-26-000050.md) |
| Diluted EPS | $ per share | not reported | [4.24](/filings/0001669162-25-000027.md) | [3.97](/filings/0001669162-25-000043.md) | [4.90](/filings/0001669162-25-000058.md) | not reported | [3.83](/filings/0001669162-26-000026.md) | [5.76](/filings/0001669162-26-000040.md) | [6.09](/filings/0001669162-26-000050.md) | not reported | [4.88](/filings/0001669162-26-000026.md) | [7.72](/filings/0001669162-26-000040.md) | [4.36](/filings/0001669162-26-000050.md) |
| Basic EPS | $ per share | not reported | [4.28](/filings/0001669162-25-000027.md) | [4.00](/filings/0001669162-25-000043.md) | [4.93](/filings/0001669162-25-000058.md) | not reported | [3.85](/filings/0001669162-26-000026.md) | [5.79](/filings/0001669162-26-000040.md) | [6.12](/filings/0001669162-26-000050.md) | not reported | [4.90](/filings/0001669162-26-000026.md) | [7.73](/filings/0001669162-26-000040.md) | [4.36](/filings/0001669162-26-000050.md) |

- Revenue: us-gaap:Revenues
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [127](/filings/0001669162-24-000041.md) | [136](/filings/0001669162-24-000020.md) | [171](/filings/0001669162-24-000028.md) | [112](/filings/0001669162-24-000041.md) | [113](/filings/0001669162-25-000058.md) | [142](/filings/0001669162-25-000027.md) | [138](/filings/0001669162-25-000043.md) | [170](/filings/0001669162-25-000058.md) | [163](/filings/0001669162-26-000050.md) | [223](/filings/0001669162-26-000026.md) | [211](/filings/0001669162-26-000040.md) | [161](/filings/0001669162-26-000050.md) |
| Total assets | $m | [3,773](/filings/0001669162-25-000010.md) | [4,031](/filings/0001669162-24-000020.md) | [4,395](/filings/0001669162-24-000028.md) | [4,732](/filings/0001669162-24-000041.md) | [4,887](/filings/0001669162-26-000015.md) | [5,215](/filings/0001669162-25-000027.md) | [5,557](/filings/0001669162-25-000043.md) | [5,833](/filings/0001669162-25-000058.md) | [6,044](/filings/0001669162-26-000050.md) | [6,215](/filings/0001669162-26-000026.md) | [6,429](/filings/0001669162-26-000040.md) | [6,431](/filings/0001669162-26-000050.md) |
| Total liabilities | $m | [2,686](/filings/0001669162-25-000010.md) | [2,860](/filings/0001669162-24-000020.md) | [3,138](/filings/0001669162-24-000028.md) | [3,297](/filings/0001669162-24-000041.md) | [3,403](/filings/0001669162-26-000015.md) | [3,632](/filings/0001669162-25-000027.md) | [3,834](/filings/0001669162-25-000043.md) | [3,968](/filings/0001669162-25-000058.md) | [4,084](/filings/0001669162-26-000050.md) | [4,248](/filings/0001669162-26-000026.md) | [4,394](/filings/0001669162-26-000040.md) | [4,512](/filings/0001669162-26-000050.md) |
| Long-term debt | $m | [184](/filings/0001669162-25-000010.md) | [184](/filings/0001669162-24-000020.md) | [184](/filings/0001669162-24-000028.md) | [184](/filings/0001669162-24-000041.md) | [184](/filings/0001669162-26-000015.md) | [184](/filings/0001669162-25-000027.md) | [184](/filings/0001669162-25-000043.md) | [199](/filings/0001669162-25-000058.md) | [224](/filings/0001669162-26-000050.md) | [224](/filings/0001669162-26-000026.md) | [225](/filings/0001669162-26-000040.md) | [225](/filings/0001669162-26-000050.md) |
| Shareholders' equity | $m | [1,087](/filings/0001669162-26-000015.md) | [1,171](/filings/0001669162-25-000058.md) | [1,257](/filings/0001669162-25-000058.md) | [1,435](/filings/0001669162-25-000058.md) | [1,484](/filings/0001669162-26-000050.md) | [1,583](/filings/0001669162-26-000050.md) | [1,723](/filings/0001669162-26-000050.md) | [1,865](/filings/0001669162-26-000050.md) | [1,960](/filings/0001669162-26-000050.md) | [1,967](/filings/0001669162-26-000050.md) | [2,035](/filings/0001669162-26-000050.md) | [1,919](/filings/0001669162-26-000050.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [212 d](/filings/0001669162-26-000015.md) | [210](/filings/0001669162-25-000027.md) | [279 d](/filings/0001669162-25-000043.md) | [274 d](/filings/0001669162-25-000058.md) | [213 d](/filings/0001669162-26-000015.md) | [230](/filings/0001669162-26-000026.md) | [269 d](/filings/0001669162-26-000040.md) | [303 d](/filings/0001669162-26-000050.md) | [241 d](/filings/0001669162-26-000015.md) | [249](/filings/0001669162-26-000026.md) | [242 d](/filings/0001669162-26-000040.md) | [264 d](/filings/0001669162-26-000050.md) |
| Capital expenditure | $m | [1.1 d](/filings/0001669162-26-000015.md) | [3.5](/filings/0001669162-25-000027.md) | [3.8 d](/filings/0001669162-25-000043.md) | [5.8 d](/filings/0001669162-25-000058.md) | [10.8 d](/filings/0001669162-26-000015.md) | [12.1](/filings/0001669162-26-000026.md) | [17.0 d](/filings/0001669162-26-000040.md) | [13.9 d](/filings/0001669162-26-000050.md) | [10.6 d](/filings/0001669162-26-000015.md) | [7.6](/filings/0001669162-26-000026.md) | [2.8 d](/filings/0001669162-26-000040.md) | [2.3 d](/filings/0001669162-26-000050.md) |
| Dividends paid | $m | [3.2 d](/filings/0001669162-26-000015.md) | [3.5](/filings/0001669162-25-000027.md) | [3.5 d](/filings/0001669162-25-000043.md) | [3.5 d](/filings/0001669162-25-000058.md) | [3.5 d](/filings/0001669162-26-000015.md) | [4.0](/filings/0001669162-26-000026.md) | [3.9 d](/filings/0001669162-26-000040.md) | [3.9 d](/filings/0001669162-26-000050.md) | [3.9 d](/filings/0001669162-26-000015.md) | [5.8](/filings/0001669162-26-000026.md) | [5.7 d](/filings/0001669162-26-000040.md) | [5.6 d](/filings/0001669162-26-000050.md) |
| Share repurchases | $m | not reported | [0.0](/filings/0001669162-25-000027.md) | [0.0 d](/filings/0001669162-25-000043.md) | [0.0 d](/filings/0001669162-25-000058.md) | [10.0 d](/filings/0001669162-26-000015.md) | [10.0](/filings/0001669162-26-000026.md) | [10.0 d](/filings/0001669162-26-000040.md) | [20.0 d](/filings/0001669162-26-000050.md) | [50.0 d](/filings/0001669162-26-000015.md) | [62.5](/filings/0001669162-26-000026.md) | [101 d](/filings/0001669162-26-000040.md) | [100 d](/filings/0001669162-26-000050.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [23.3](/filings/0001669162-24-000020.md) | [23.3](/filings/0001669162-24-000028.md) | [23.3](/filings/0001669162-24-000041.md) | [23.3](/filings/0001669162-25-000027.md) | [23.3](/filings/0001669162-25-000043.md) | [23.3](/filings/0001669162-25-000058.md) | [23.3](/filings/0001669162-26-000026.md) | [23.3](/filings/0001669162-26-000040.md) | [23.3](/filings/0001669162-26-000050.md) | [23.1](/filings/0001669162-26-000026.md) | [22.8](/filings/0001669162-26-000040.md) | [22.5](/filings/0001669162-26-000050.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,509,945 at 2026-10-16, from the cover of the [10-Q filed 2026-10-22](/filings/0001669162-26-000050.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.